. 2016 Jan 9;7(7):7856–7865. doi: 10.18632/oncotarget.6856

Table 1. GPR171 is upregulated in a subset of lung cancer tissues.

Clinical types of lung cancer	Number of stained samples/examined samples			Total positive tissues
Clinical types of lung cancer	Strong	Moderate	Negative	Total positive tissues
Cancer	8/47	14/47	25/47	22/47 (46.8%)
NSCLC	4/35	12/35	19/35	16/35 (45.7%)
SCLC	1/3	1/3	1/3	2/3
Metastasis	3/9	1/9	5/9	4/9
Normal	0/9	2/9	7/9	2/9

Immunohistochemical quantification of GPR171 in lung cancer and normal tissues. Strong, moderate, and negative indicate >50%, 10-50%, and <10% positive cells, respectively.